NewAmsterdam Pharma Co N.V.
NAMS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001936258
In the last 90 days, NewAmsterdam Pharma Co N.V. insiders filed 1 open-market purchase and 4 sales; 194 institutions reported holding it in 13F filings for Q2 2026, worth $4.13B in total; 3 superinvestors hold it, including Viking Global Investors and Maverick Capital.
Other share classesNAMSW
Q3 2023 vs. Q2 2023
How the institutions holding NewAmsterdam Pharma Co N.V. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 29 | 35 | +6 |
| Shares | 48.8M | 50.2M | +1.34M (+2.8%) |
| Value | $580.6M | $464.1M | −$116.5M (−20.1%) |
New holders (9)
Institutions that held NewAmsterdam Pharma Co N.V. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Janus Henderson Group PLC | 434,912 | $3.97M | 0.00% |
| UBS Oconnor LLC | 45,000 | $416.3K | 0.01% |
| Citadel Advisors LLC | 31,397 | $290.4K | 0.00% |
| BlackRock Inc. | 22,941 | $212.2K | 0.00% |
| Parkwood LLC | 20,209 | $187.0K | 0.03% |
| CIBC Private Wealth Group, LLC | 13,000 | $120.3K | 0.00% |
| Wolverine Asset Management LLC | 2,925 | $27.1K | 0.00% |
| Royal Bank of Canada | 1,000 | $9.00K | 0.00% |
| Barclays PLC | 513 | $4.75K | 0.00% |
Sold out (3)
Institutions that held NewAmsterdam Pharma Co N.V. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Deerfield Management Company, L.P. (Series C) | 2,535,723 | $30.1M |
| Monashee Investment Management LLC | 95,000 | $1.13M |
| UBS Group AG | 183 | $2.18K |